Tagged Articles

cardiovascular risk 21 articles

Diet pill maker refuses to take ‘no’ from FDA

Arena Pharmaceuticals and Eisai Co. are not ready to throw in the towel with their new weight-loss drug lorcaserin, arguing that it has data from a new study that shows lorcaserin is strong enough to win approval by the Food and Drug Administration (FDA). The agency had rejected the drug’s last proposal in October questioning whether the older study, which involved diabetic patients, was too small to measure the benefit/risk profile. The agency also raised concerns about early animal trials that showed the drug caused cancerous tumors in laboratory rats. The new data shows that 37.5 percent of patients taking ... Read More